PMDA drug package insert
カナリア配合錠
PMDA Prescription drug · 田辺ファーマ株式会社 · package insert Aug 7, 2026
Key facts
| Brand names | カナリア配合錠, カナリア配合OD錠 |
|---|---|
| Nonproprietary names | テネリグリプチン臭化水素酸塩水和物・カナグリフロジン水和物配合剤 |
| Companies | 製造販売元／田辺ファーマ株式会社, 販売元／第一三共株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 選択的DPP-4阻害剤/SGLT2阻害剤 配合剤; -2型糖尿病治療剤- |
| Therapeutic category codes | 873969 |
| YJ codes | 3969106F1028, 3969106F2024 |
| Approval numbers | 22900AMX00578, 30700AMX00006 |
| Package insert edition | 第8版 |
| Package insert date | Aug 7, 2026 |
| PMDA document key | 400315_3969106F1028_1 |
| PMDA company code | 400315 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: